MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 67 filers reported holding MINERVA NEUROSCIENCES INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $36,000 | -45.5% | 15,578 | -45.2% | 0.00% | – |
| Q4 2020 | $66,000 | -20.5% | 28,414 | +23.6% | 0.00% | -100.0% |
| Q2 2020 | $83,000 | -39.0% | 22,990 | +2.0% | 0.00% | -66.7% |
| Q1 2020 | $136,000 | -89.3% | 22,549 | -87.4% | 0.00% | -62.5% |
| Q4 2019 | $1,271,000 | +244.4% | 178,779 | +275.4% | 0.01% | +166.7% |
| Q3 2019 | $369,000 | -37.0% | 47,627 | -54.3% | 0.00% | -50.0% |
| Q2 2019 | $586,000 | -41.9% | 104,171 | -18.7% | 0.01% | -45.5% |
| Q1 2019 | $1,008,000 | +51.4% | 128,206 | +29.7% | 0.01% | +37.5% |
| Q4 2018 | $666,000 | -12.3% | 98,812 | +63.5% | 0.01% | -11.1% |
| Q3 2018 | $759,000 | +150.5% | 60,442 | +64.7% | 0.01% | +125.0% |
| Q2 2018 | $303,000 | +55.4% | 36,700 | +17.6% | 0.00% | +33.3% |
| Q1 2018 | $195,000 | +26.6% | 31,200 | +23.0% | 0.00% | 0.0% |
| Q4 2017 | $154,000 | +26.2% | 25,376 | +144.7% | 0.00% | -40.0% |
| Q4 2016 | $122,000 | – | 10,369 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,652,436 | $31,166,000 | 4.20% |
| NEXTHERA CAPITAL LP | 492,958 | $5,792,000 | 3.40% |
| Iguana Healthcare Management, LLC | 150,000 | $1,763,000 | 1.05% |
| Perceptive Advisors | 810,537 | $9,523,000 | 0.68% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,141,333 | $13,411,000 | 0.63% |
| FEDERATED HERMES, INC. | 6,358,642 | $74,714,000 | 0.22% |
| EAM Investors, LLC | 137,685 | $1,618,000 | 0.22% |
| Orbimed Advisors | 556,200 | $6,535,000 | 0.08% |
| J. Goldman & Co LP | 103,281 | $1,214,000 | 0.08% |
| Virtus ETF Advisers LLC | 18,814 | $221,000 | 0.07% |